 |
|
The flavonoid fisetin ameliorates renal fibrosis by inhibiting SMAD3 phosphorylation, oxidative damage, and
inflammation in ureteral obstructed kidney in mice
Ha Young Ju, Jongwan Kim, Sang Jun Han
Kidney Res Clin Pract. 2023;42(3):325-339. Published online 2023 Mar 22 DOI: https://doi.org/10.23876/j.krcp.22.034
|
|
Citations to this article as recorded by
 Targeting senescence to prevent diabetic kidney disease: Exploring molecular mechanisms and potential therapeutic targets for disease management
Paige Charlotte Alison Phillips, Mafalda de Sousa Loreto Aresta Branco, Chelsy Louise Cliff, Joanna Kate Ward, Paul Edward Squires, Claire Elizabeth Hills
Diabetic Medicine.2025;[Epub] CrossRef Renal macrophages and NLRP3 inflammasomes in kidney diseases and therapeutics
Mohammad Islamuddin, Xuebin Qin
Cell Death Discovery.2024;[Epub] CrossRef Hederagenin improves renal fibrosis in diabetic nephropathy by regulating Smad3/NOX4/SLC7A11 signaling-mediated tubular cell ferroptosis
Jian jia, Ruizhi Tan, Linghui Xu, Honglian Wang, Jianchun Li, Hongwei Su, Xia Zhong, Peng Liu, Li Wang
International Immunopharmacology.2024; 135: 112303. CrossRef Association between dietary intake of flavonoid and chronic kidney disease in US adults: Evidence from NHANES 2007-2008, 2009-2010, and 2017-2018
Peijia Liu, Wujian Peng, Feng Hu, Guixia Li, Tauqeer Hussain Mallhi
PLOS ONE.2024; 19(8): e0309026. CrossRef The flavonoid fisetin reduces multiple physiological risk factors for dementia
Pamela Maher
Neurochemistry International.2024; 178: 105805. CrossRef Pathogenesis and management of renal fibrosis induced by unilateral ureteral obstruction
Qi Yan Nan, Shang Guo Piao, Ji Zhe Jin, Byung Ha Chung, Chul Woo Yang, Can Li
Kidney Research and Clinical Practice.2024; 43(5): 586. CrossRef Fisetin as a senotherapeutic agent: Evidence and perspectives for age-related diseases
Juliette Tavenier, Jan O. Nehlin, Morten Baltzer Houlind, Lene Juel Rasmussen, Tamara Tchkonia, James L. Kirkland, Ove Andersen, Line Jee Hartmann Rasmussen
Mechanisms of Ageing and Development.2024; 222: 111995. CrossRef An insight into fisetin, the miraculous multifaceted flavonol: Paving the road for enhanced delivery through promising pharmaceutical nano-formulations
Asmaa H. Elwan, Soha M. El-Masry, Doaa A. Habib, Mariam Zewail
Journal of Drug Delivery Science and Technology.2024; 101: 106292. CrossRef The protective effects of fisetin in metabolic disorders: a focus on oxidative stress and associated events
Mahboobe Sattari, Jamal Amri, Mohammad Esmaeil Shahaboddin, Mohadese Sattari, Ozra Tabatabaei-Malazy, Marzyeh Azmon, Reza Meshkani, Ghodratollah Panahi
Journal of Diabetes & Metabolic Disorders.2024; 23(2): 1753. CrossRef A therapeutic approach to identify leading molecules from natural products and therapeutic targets in CKD by network pharmacology
Yugant Krishnakumar Talati, Anil Bhanudas Gaikwad
PharmaNutrition.2024; 30: 100421. CrossRef A novel strategy employing the flavonoid fisetin to halt the progression of renal fibrosis in obstructive nephropathy
Tae-Hwan Kwon
Kidney Research and Clinical Practice.2023; 42(3): 282. CrossRef Effects of Fisetin Treatment on Cellular Senescence of Various Tissues and Organs of Old Sheep
Charles A. Huard, Xueqin Gao, Maria E. Dey Hazra, Rony-Orijit Dey Hazra, Kimberly Lebsock, Jeremiah T. Easley, Peter J. Millett, Johnny Huard
Antioxidants.2023; 12(8): 1646. CrossRef Macrophage polarization in tissue fibrosis
Huidan Yang, Hao Cheng, Rongrong Dai, Lili Shang, Xiaoying Zhang, Hongyan Wen
PeerJ.2023; 11: e16092. CrossRef Fisetin Treats Kidney Oxidative Stress, Inflammation, and Apoptosis in Rat Diarrhea
Khaled M. M. Koriem, Yousra K. O. Farouk
Frontiers in Bioscience-Scholar.2023;[Epub] CrossRef
|